Immunic, Inc.
DE ˙ DB
16,63 € ↓ -16,55 (-49,87%)
2019-04-18
CENA AKCJI
SecurityDE:10V / Immunic, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership3,288,540 shares
Latest Disclosed Value $ 3,650,280
Morgan Stanley reports 57.27% increase in ownership of 10V / Immunic, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 3,288,540 shares of Immunic, Inc. (DE:10V) valued at $3,650,280 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 2,091,011 shares of Immunic, Inc.. This represents a change in shares of 57.27% during the quarter. The current value of the position is $54,694,997 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNIC COM 4525EP101 3,288,540 1,197,529 57.27 3,650 227.35 0.0002
2026-05-27 2025-12-31 13F/A-1 IMMUNIC COM 4525EP101 2,091,011 -1,012,111 -32.62 1,116 -59.23 0.0001
2026-02-13 2025-12-31 13F IMMUNIC COM 4525EP101 2,091,011 -1,012,111 1,116
2026-05-27 2025-09-30 13F/A-1 IMMUNIC COM 4525EP101 3,103,122 -525,406 -14.48 2,736 8.10 0.0002
2025-11-14 2025-09-30 13F IMMUNIC COM 4525EP101 3,103,122 -525,406 2,736 0.0002
2025-08-15 2025-06-30 13F IMMUNIC COM 4525EP101 3,628,528 3,060,916 539.26 2,531 309.39 0.0002
2025-05-15 2025-03-31 13F IMMUNIC COM 4525EP101 567,612 -537,144 -48.62 619 -44.02 0.0000
2025-05-15 2024-12-31 13F/A-1 IMMUNIC COM 4525EP101 1,104,756 714,046 182.76 1,105 71.43 0.0001
2025-02-14 2024-12-31 13F IMMUNIC COM 4525EP101 1,104,756 714,046 1,105 0.0001
2025-05-14 2024-09-30 13F/A-2 IMMUNIC COM 4525EP101 390,710 365,306 1,437.99 645 2,200.00 0.0000
2025-02-14 2024-09-30 13F/A-1 IMMUNIC COM 4525EP101 390,710 365,306 645 0.0000
2024-11-14 2024-09-30 13F IMMUNIC COM 4525EP101 390,710 365,306 645 0.0000
2025-05-14 2024-06-30 13F/A-2 IMMUNIC COM 4525EP101 25,404 -4,905 -16.18 28 -30.00 0.0000
2024-10-17 2024-06-30 13F/A-1 IMMUNIC COM 4525EP101 25,404 -4,905 28 0.0000
2024-08-14 2024-06-30 13F IMMUNIC COM 4525EP101 25,404 -4,905 28 0.0000
2024-10-17 2024-03-31 13F/A-2 IMMUNIC COM 4525EP101 30,309 13,924 84.98 40 66.67 0.0000
2024-08-16 2024-03-31 13F/A-1 IMMUNIC COM 4525EP101 30,309 13,924 40 0.0000
2024-05-15 2024-03-31 13F IMMUNIC COM 4525EP101 30,309 13,924 40 0.0000
2024-08-16 2023-12-31 13F/A-1 IMMUNIC COM 4525EP101 16,385 -15,709 -48.95 25 -48.94 0.0000
2024-02-13 2023-12-31 13F IMMUNIC COM 4525EP101 16,385 -15,709 25 0.0000
2023-11-15 2023-09-30 13F IMMUNIC COM 4525EP101 32,094 -25,011 -43.80 47 -67.13 0.0000
2023-08-14 2023-06-30 13F IMMUNIC COM 4525EP101 57,105 -467,370 -89.11 143 -81.69 0.0000
2023-05-15 2023-03-31 13F IMMUNIC COM 4525EP101 524,475 50,098 10.56 781 17.62 0.0001
2023-02-14 2022-12-31 13F IMMUNIC COM 4525EP101 474,377 456,492 2,552.37 664 1,085.71 0.0001
2022-11-14 2022-09-30 13F IMMUNIC COM 4525EP101 17,885 -21,352 -54.42 56 -58.82 0.0000
2022-10-27 2022-06-30 13F/A-1 IMMUNIC COM 4525EP101 39,237 15,427 64.79 136 -49.44 0.0000
2022-08-15 2022-06-30 13F IMMUNIC COM 4525EP101 39,237 15,427 136 0.0000
2022-10-27 2022-03-31 13F/A-1 IMMUNIC COM 4525EP101 23,810 -35,408 -59.79 269 -52.56 0.0000
2022-05-13 2022-03-31 13F IMMUNIC COM 4525EP101 23,810 -35,408 269 0.0000
2022-02-14 2021-12-31 13F IMMUNIC COM 4525EP101 59,218 48,433 449.08 567 496.84 0.0001
2021-11-15 2021-09-30 13F IMMUNIC COM 4525EP101 10,785 2,023 23.09 95 -12.04 0.0000
2021-08-23 2021-06-30 13F/A-1 IMMUNIC COM 4525EP101 8,762 8,700 14,032.26 108 10,700.00 0.0000
2021-08-16 2021-06-30 13F IMMUNIC COM 4525EP101 8,762 8,700 108 0.0000
2021-05-17 2021-03-31 13F IMMUNIC COM 4525EP101 62 -4,117 -98.52 1 -98.44 0.0000
2021-02-16 2020-12-31 13F IMMUNIC COM 4525EP101 4,179 3,487 503.90 64 392.31 0.0000
2020-11-13 2020-09-30 13F IMMUNIC COM 4525EP101 692 -476 -40.75 13 -7.14 0.0000
2020-08-14 2020-06-30 13F IMMUNIC COM 4525EP101 1,168 1,021 694.56 14 1,300.00 0.0000
2020-05-26 2020-03-31 13F/A-1 IMMUNIC COM 4525EP101 147 0 0.00 1 0.00 0.0000
2020-05-15 2020-03-31 13F IMMUNIC COM 4525EP101 147 0 1 0.0768
2020-02-14 2019-12-31 13F IMMUNIC COM 4525EP101 147 -1 -0.68 1 0.00 0.0000
2019-11-14 2019-09-30 13F IMMUNIC COM 4525EP101 148 -101 -40.56 1 -66.67 0.0000
2019-08-14 2019-06-30 13F IMMUNIC COM 4525EP101 249 -18,149 -98.65 3 -25.00 0.0000
2019-05-15 2019-03-31 13F VITAL THERAPIES COM 92847R104 18,398 -62,729 -77.32 4 -73.33 0.0000
2019-02-14 2018-12-31 13F VITAL THERAPIES COM 92847R104 81,127 -81,583 -50.14 15 -66.67 0.0000
2019-04-23 2018-09-30 13F/A-2 VITAL THERAPIES COM 92847R104 162,710 90,528 125.42 45 -90.91 0.0000
2018-11-20 2018-09-30 13F/A-1 VITAL THERAPIES COM 92847R104 162,710 0 45 0.0000
2018-11-14 2018-09-30 13F VITAL THERAPIES COM 92847R104 162,710 90,528 45
2019-04-23 2018-06-30 13F/A-1 VITAL THERAPIES COM 92847R104 72,182 29,409 68.76 495 70.10 0.0001
2018-08-14 2018-06-30 13F VITAL THERAPIES COM 92847R104 72,182 29,409 495
2019-04-23 2018-03-31 13F/A-1 VITAL THERAPIES COM 92847R104 42,773 17,041 66.22 291 90.20 0.0001
2018-05-14 2018-03-31 13F VITAL THERAPIES COM 92847R104 42,773 17,041 291
2019-04-23 2017-12-31 13F/A-1 VITAL THERAPIES COM 92847R104 25,732 24,449 1,905.61 153 2,450.00 0.0000
2018-02-14 2017-12-31 13F VITAL THERAPIES COM 92847R104 25,732 24,449 153
2017-11-14 2017-09-30 13F VITAL THERAPIES COM 92847R104 1,283 -2,488 -65.98 6 -45.45 0.0000
2017-08-11 2017-06-30 13F VITAL THERAPIES COM 92847R104 3,771 -28,458 -88.30 11 -91.47 0.0000
2017-05-22 2017-03-31 13F/A-1 VITAL THERAPIES COM 92847R104 32,229 -37,949 -54.08 129 -57.70 0.0000
2017-05-12 2017-03-31 13F VITAL THERAPIES COM 92847R104 32,229 129
2017-02-22 2016-12-31 13F/A-1 VITAL THERAPIES COM 92847R104 70,178 63,720 986.68 305 682.05 0.0001
2017-02-13 2016-12-31 13F VITAL THERAPIES COM 92847R104 70,178 305
2016-11-10 2016-09-30 13F VITAL THERAPIES COM 92847R104 6,458 3,207 98.65 39 95.00 0.0000
2016-08-12 2016-06-30 13F VITAL THERAPIES COM 92847R104 3,251 -6,466 -66.54 20 -77.27 0.0000
2016-05-12 2016-03-31 13F VITAL THERAPIES COM 92847R104 9,717 -44,187 -81.97 88 -85.83 0.0000
2016-02-09 2015-12-31 13F VITAL THERAPIES COM 92847R104 53,904 49,071 1,015.33 621 3,168.42 0.0002
2016-02-08 2015-09-30 13F/A-1 VITAL THERAPIES COM 92847R104 4,833 -1,687 -25.87 19 -86.23 0.0000
2015-11-09 2015-09-30 13F VITAL THERAPIES COM 92847R104 4,833 19
2015-08-12 2015-06-30 13F VITAL THERAPIES COM 92847R104 6,520 -5,308 -44.88 138 -53.22 0.0000
2015-05-14 2015-03-31 13F VITAL THERAPIES COM 92847R104 11,828 1,996 20.30 295 20.41 0.0001
2015-02-13 2014-12-31 13F VITAL THERAPIES COM 92847R104 9,832 9,555 3,449.46 245 3,983.33 0.0001
2014-12-16 2014-09-30 13F/A-1 VITAL THERAPIES COM 92847R104 277 277 6 0.0000
2014-11-14 2014-09-30 13F VITAL THERAPIES COM 92847R104 277 6 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.